Diabetes and prediabetes in patients with hepatitis B residing in North America

Hepatology

Volumn 62, Issue 5, 2015, Pages 1364-1374

  Khalili, Mandana ^a   Lombardero, Manuel ^b   Chung, Raymond T ^c   Terrault, Norah A ^a   Ghany, Marc G ^d   Kim, W Ray ^e   Lau, Daryl ^f   Lisker Melman, Mauricio ^g   Sanyal, Arun ^h   Lok, Anna S ⁱ   Roberts, Lewis R ^j   Smith, Coleman I ^k   Di Bisceglie, Adrian M ^l   Brunt, Elizabeth M ^m   Janssen, Harry L A ⁿ   Wong, David K ⁿ   Juan, Joshua ⁿ   Feld, Jordan ⁿ   Yim, Colina ⁿ   Heathcote, Jenny ⁿ   Lee, William M ^o   Perrillo, Robert ^p   Do, Son ^o   Han, Steven Huy B ^q   Tran, Tram T ^r   Cooper, Stewart L ^s   Fontana, Robert J ⁱ   Tsai, Naoky ^t   Fried, Michael W ^u   Patel, Keyur ^v   Evon, Donna ^u   Carithers, Robert C ^w   Shuhart, Margaret ^x   Kowdley, Kris V ^y   Wang, Chia C ^x   Sterling, Richard K ^z   Jake Liang, T ^d   Chang, Kyong Mi ^aa   Park, Jang June ^aa   Belle, Steven ^ab   Wahed, Abdus ^ab   Cloonan, Yona ^ab   Kleiner, David ^ac   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e STANFORD UNIVERSITY   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

ⁱ UNIVERSITY OF MICHIGAN   (United States)

^j MAYO CLINIC ROCHESTER   (United States)

^k UNIVERSITY OF MINNESOTA   (United States)

^l SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m WASHINGTON UNIVERSITY   (United States)

ⁿ TORONTO WESTERN HOSPITAL   (Canada)

^o UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^p BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r CEDARS SINAI MEDICAL CENTER   (United States)

^s CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^t QUEEN S MEDICAL CENTER   (United States)

^u UNIVERSITY OF NORTH CAROLINA   (United States)

^v DUKE UNIVERSITY MEDICAL CENTER   (United States)

^w UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^x UNIVERSITY OF WASHINGTON   (United States)

^y VIRGINIA MASON MEDICAL CENTER   (United States)

^z VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^aa UNIVERSITY OF PENNSYLVANIA   (United States)

^ab UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^ac NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA; GLUCOSE BLOOD LEVEL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; ARTICLE; ASIAN; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLACK PERSON; BODY MASS; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; ENDOCRINE FUNCTION TEST; ETHNIC DIFFERENCE; FAMILY HISTORY; FEMALE; GLUCOSE METABOLISM; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; LIVER FIBROSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MIGRATION; NORTH AMERICA; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; WAIST CIRCUMFERENCE; ANALYSIS; BLOOD; CHRONIC HEPATITIS B; COMPLICATION; CROSS-SECTIONAL STUDY; GLUCOSE BLOOD LEVEL; PREDIABETIC STATE;

ADULT; ALANINE TRANSAMINASE; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HEPATITIS B, CHRONIC; HUMANS; MALE; PREDIABETIC STATE; PREVALENCE;

EID: 84945218153     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28110     Document Type: Article

References (40)

1. Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis-United States, 2007. MMWR Surveill Summ 2009;58:1-27.
2. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009;50:661-662.
3. Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology 2012;56:422-433.
4. McMahon BJ. Chronic hepatitis B virus infection. Med Clin North Am 2014;98:39-54.
5. Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011;9:524-530.e1; quiz, e560.
6. Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK, et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 2009;58:111-117.
7. Wang YY, Lin SY, Sheu WH, Liu PH, Tung KC. Obesity and diabetic hyperglycemia were associated with serum alanine aminotransferase activity in patients with hepatitis B infection. Metabolism 2010;59:486-491.
8. Lee IC, Huang YH, Chan CC, Huo TI, Chu CJ, Lai CR, et al. Impact of body mass index and viral load on liver histology in hepatitis B e antigen-negative chronic hepatitis B. Clin Nutr 2011;30:647-652.
9. Wong GL, Chan HL, Yu Z, Chan AW, Choi PC, Chim AM, et al. Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B-a prospective cohort study with paired transient elastography examinations. Aliment Pharmacol Ther 2014;39:883-893.
10. Yoon H, Lee JG, Yoo JH, Son MS, Kim DY, Hwang SG, Rim KS. Effects of metabolic syndrome on fibrosis in chronic viral hepatitis. Gut Liver 2013;7:469-474.
11. Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut 2010;59:1410-1415.
12. Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2011;60:1709-1711.
13. Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008;135:111-121.
14. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007;30:753-759.
15. National Diabetes Statistic Report. 2014. Available at: http://www.cdc.gov/diabetes/pdfs/data/2014-report-estimates-of-diabetes-and-its-burden-in-the-united-states.pdf. Accessed May 1, 2015.
16. Arao M, Murase K, Kusakabe A, Yoshioka K, Fukuzawa Y, Ishikawa T, et al. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus. J Gastroenterol 2003;38:355-360.
17. Cotler SJ, Dhamija MK, Luc BJ, Siqueira F, Bartram AH, Layden TJ, Wong SS. The prevalence and clinical correlates of elevated ALT levels in an urban Chinatown community. J Viral Hepat 2010;17:148-152.
18. Imazeki F, Yokosuka O, Fukai K, Kanda T, Kojima H, Saisho H. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients. Liver Int 2008;28:355-362.
19. Papatheodoridis GV, Chrysanthos N, Savvas S, Sevastianos V, Kafiri G, Petraki K, Manesis EK. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis. J Viral Hepat 2006;13:303-310.
20. Iroezindu MO, Isiguzo GC, Young EE. Prevalence and predictors of impaired fasting glucose among Nigerian patients with hepatitis B virus infection. Diabetes Res Clin Pract 2012;98:338-345.
21. Spradling PR, Simons B, Narayanan M, Xing J, Homan C, Bulkow L, et al. Incidence of diabetes mellitus in a population-based cohort of persons with chronic hepatitis B virus infection. J Viral Hepat 2013;20:510-513.
22. Ghany M, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA, et al. Characteristics of adults in the Hepatitis B Research Network in North America reflect their country of origin and HBV genotype. Clin Gastroenterol Hepatol 2015;13:183-192.
23. Standards of medical care in diabetes-2015. Diabetes Care 2015;38(Suppl 1):S5-S87.
24. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37(Suppl 1):S81-90.
25. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163.
26. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
27. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526.
28. National Institute of Alcohol and Alcoholism. Available at: http://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/moderate-binge-drinking. Accessed January 15, 2015.
29. Chow W. A look at various estimators in logistic models in the presence of missing values. In: Proceedings of Business and Economics Section, American Statistical Association. Washington, DC: The Rand Corporation; 1979:417-420.
30. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311-321.
31. Yisahak SF, Beagley J, Hambleton IR, Narayan KM. Diabetes in North America and the Caribbean: an update. Diabetes Res Clin Pract 2014;103:223-230.
32. Vanni E, Abate ML, Gentilcore E, Hickman I, Gambino R, Cassader M, et al. Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C. Hepatology 2009;50:697-706.
33. Burman BE, Bacchetti P, Ayala CE, Gelman N, Melgar J, Khalili M. Liver inflammation is a risk factor for prediabetes in at-risk latinos with and without hepatitis C infection. Liver Int 2015;35:101-107.
34. Bolukbas C, Bolukbas FF, Horoz M, Aslan M, Celik H, Erel O. Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect Dis 2005;5:95.
35. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65-73.
36. Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006;130:678-686.
37. Corlin L, Woodin M, Thanikachalam M, Lowe L, Brugge D. Evidence for the healthy immigrant effect in older Chinese immigrants: a cross-sectional study. BMC Public Health 2014;14:603.
38. Koya DL, Egede LE. Association between length of residence and cardiovascular disease risk factors among an ethnically diverse group of United States immigrants. J Gen Intern Med 2007;22:841-846.
39. Afable-Munsuz A, Mayeda ER, Perez-Stable EJ, Haan MN. Immigrant generation and diabetes risk among Mexican Americans: the Sacramento Area Latino Study on Aging. Am J Public Health 2013;103:e45-e52.
40. Bullard KM, Saydah SH, Imperatore G, Cowie CC, Gregg EW, Geiss LS, et al. Secular changes in U.S. Prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: National Health and Nutrition Examination Surveys, 1999-2010. Diabetes Care 2013;36:2286-2293.